title: Treatment of cancer-related fatigue: an update.
abstract: Fatigue, a common complaint of cancer patients, requires a multidisciplinary evaluation and treatment approach because of the multiple etiologies and contributing factors. Current treatments for fatigue include educating patients and caregivers about fatigue, applying etiology-specific treatments, utilizing nonpharmacologic interventions, and prescribing pharmacologic therapies. Often, an individualized treatment plan that includes several modalities may be developed. Presently, there is a lack of well-designed clinical trials to evaluate pharmacologic agents for the treatment of cancer-related fatigue.
authors.affiliation: Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, Unit 437, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. cescalan@mdacc.tmc.edu
authors.forename: Carmen P
authors.initials: CP
authors.lastname: Escalante
mesh_terms: D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D015444:Exercise; D005221:Fatigue / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D009369:Neoplasms / Q000150:complications*; D011788:Quality of Life
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate